Fig. 4From: The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysisProportion of patients achieving target serum phosphate (≤ 1.78 mmol/L) by country. *p < 0.05; **p < 0.001; ***p < 0.0001 (vs baseline); aThe serum phosphate data for Russia for Q3 and Q4 are not shown because the number of patients with follow-up data available was too low for meaningful analysis (Q3, n = 7; Q4, n = 0)Back to article page